-
Study aim
-
Determining and comparing the effect of high-power and low-power laser and drug therapy in improving the symptoms, function, and sonographic findings in patients with carpal tunnel syndrome
-
Design
-
A randomized, double-blind clinical trial with the parallel groups; on 66 patients. Randomization by lottery
-
Settings and conduct
-
In this randomized double-blind clinical trial study, 66 eligible patients referred to Amin Hospital in Isfahan will be included in the study and randomly divided into three groups. For patients in the first group, splints, gabapentin, and vitamin B1, in the second and third groups, in addition to the mentioned treatment, low-power laser and high-power laser are performed, respectively. The intervention will be performed in such a way that the patient and the investigator, outcome assessor, and data analyzer will have no knowledge of the type of intervention. Then the symptoms, function and sonographic findings will be compared between the three groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria include patients with mild to moderate degrees of carpal tunnel syndrome in the age group over 18 years and no history of carpal tunnel injection in a recent month and consent to participate in the study.
Exclusion criteria include having neuropathic diseases, having systemic diseases that affect treatment, having a history of carpal tunnel surgery, and pregnancy.
-
Intervention groups
-
Control group: For patients in this group, splints, gabapentin, and vitamin B1 are prescribed.
Intervention group 1: In this group, in addition to splint administration, gabapentin, and vitamin B1, patients undergo low-power laser.
Second intervention group: In this group, in addition to prescribing splints, gabapentin, and vitamin B1, patients undergo high-power laser.
-
Main outcome variables
-
Symptoms; Functional status; Pain; Nerve and muscle strip
findings; Ultrasound findings